Jorgensen H S, Kammersgaard L P, Houth J, Nakayama H, Raaschou H O, Larsen K, Hübbe P, Olsen T S
Department of Neurology, Bispebjerg Hospital, Copenhagen, Denmark.
Stroke. 2000 Feb;31(2):434-9. doi: 10.1161/01.str.31.2.434.
The beneficial effects of treatment and rehabilitation of patients with acute stroke in a dedicated stroke unit (SU) are well established. We wanted to examine if these effects are limited to certain groups of patients or if they apply to all patients independent of age, sex, comorbidity, and initial stroke severity.
This was a community-based study of outcome in 1241 consecutive stroke patients from 2 communities in Copenhagen: In one (Frederiksberg), treatment and rehabilitation were given in general neurological and medical wards (GW), and in the other (Bispebjerg) in one single large SU. Outcome measures were initial, 1-year, and 5-year mortality rates, a poor outcome (initial death or discharge to a nursing home), and length of hospital stay (LOHS). Multivariate regression analyses were used to examine the independent effect of SU treatment on the various subgroups.
The relative risks of initial death, poor outcome, and 1-year and 5-year mortality rates were reduced by 40% on average in patients treated in the SU compared with the GW. A beneficial effect of SU treatment was observed regardless of the patient's age, sex, comorbidity, and initial stroke severity. Those who benefited most appeared to be the patients with the most severe strokes (poor outcome: OR 0.17; 95% CI 0.05 to 0.58). Those who benefited least were patients with mild or moderate strokes (poor outcome: OR 0.66; 95% CI 0.41 to 0.98) and patients <75 years of age (poor outcome: OR 0.66; 95% CI 0.36 to 1.19). LOHS was reduced by 2 to 3 weeks in all who had their treatment in the SU except in patients with the most severe strokes. LOHS in these patients was similar to LOHS in the GW.
A beneficial effect of treatment in a SU is achieved in completely unselected patients independent of their age, sex, comorbidity, and stroke severity. Those who had the most severe strokes appeared to benefit most. All patients with acute stroke should therefore have access to treatment and rehabilitation in a dedicated SU.
在专门的卒中单元(SU)对急性卒中患者进行治疗和康复的益处已得到充分证实。我们想研究这些益处是否仅限于特定患者群体,还是适用于所有患者,而与年龄、性别、合并症及初始卒中严重程度无关。
这是一项基于社区的研究,纳入了哥本哈根两个社区的1241例连续卒中患者:其中一个社区(腓特烈斯贝)在普通神经科和内科病房(GW)进行治疗和康复,另一个社区(比斯佩布杰尔)在一个大型单一卒中单元进行治疗和康复。结局指标包括初始死亡率、1年和5年死亡率、不良结局(初始死亡或出院后入住疗养院)以及住院时间(LOHS)。采用多变量回归分析来研究卒中单元治疗对各个亚组的独立影响。
与在普通病房治疗的患者相比,在卒中单元接受治疗的患者初始死亡、不良结局以及1年和5年死亡率的相对风险平均降低了40%。无论患者的年龄、性别、合并症及初始卒中严重程度如何,均观察到卒中单元治疗的有益效果。获益最大的似乎是卒中最严重的患者(不良结局:OR 0.17;95%CI 0.05至0.58)。获益最小的是轻度或中度卒中患者(不良结局:OR 0.66;95%CI 0.41至0.98)以及年龄<75岁的患者(不良结局:OR 0.66;95%CI 0.36至1.19)。除了卒中最严重的患者外,在卒中单元接受治疗的所有患者的住院时间缩短了2至3周。这些患者的住院时间与在普通病房的住院时间相似。
在完全未经过筛选的患者中,无论其年龄、性别、合并症及卒中严重程度如何,在卒中单元进行治疗均有益处。卒中最严重的患者似乎获益最大。因此,所有急性卒中患者都应能够在专门的卒中单元接受治疗和康复。